Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing ..
medical education for physicians. Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. The bladder cancer treatment landscape is broadening with advances in immuno-oncology and targeted therapy strategies, while new clinical data continue to impact all stages of bladder cancer as more is learned about single-agent and combination immunotherapy approaches. This enduring CME activity from a live webcast on June 4, 2020, features a panel of experts who will address the application of immune-based and targeted-agent approaches through presentations and discussions of the most recent clinical data for the treatment of early and advanced bladder cancer. Practical patient case scenarios will highlight treatment decisions in various bladder cancer settings and will address the management of adverse events associated with immunotherapy and targeted agents, the importance of multidisciplinary care, and future directions in the field of bladder cancer. This educational program is directed toward urologists, oncologists, and researchers interested in the treatment of bladder cancers. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in the treatment and management of patients with bladder cancers are invited to participate.